DEFEROXAMINE MESYLATE in the United States
14 medicine records from 10 holders carry this name in the official sources. Collected on November 18, 2026.
Medicines
| Name | Holder | Code |
|---|---|---|
| Deferoxamine INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Fresenius Kabi USA, LLC |
Product NDC
63323-597Package NDC
63323-597-10
|
| Deferoxamine INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Fresenius Kabi USA, LLC |
Product NDC
63323-599Package NDC
63323-599-30
|
| Deferoxamine Mesylate INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Hospira, Inc. |
Product NDC
0409-2337Package NDC
0409-2337-25
|
| Deferoxamine Mesylate POWDER | Olon SpA |
Product NDC
17337-0060Package NDC
17337-0060-1
|
| Deferoxamine mesylate POWDER | Excella GmbH & Co. KG |
Product NDC
46014-1003Package NDC
46014-1003-1
|
| Deferoxamine mesylate POWDER | Excella GmbH & Co. KG |
Product NDC
46014-1127Package NDC
46014-1127-1
|
| Deferoxamine Mesylate POWDER | Teva Pharmaceutical Works Private Limited Company |
Product NDC
51846-1016Package NDC
51846-1016-0
|
| Deferoxamine mesylate INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Apotex Corp. |
Product NDC
60505-6236Package NDC
60505-6236-6
|
| Deferoxamine mesylate INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Apotex Corp. |
Product NDC
60505-6237Package NDC
60505-6237-6
|
| Deferoxamine mesylate INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Gland Pharma Limited |
Product NDC
68083-172Package NDC
68083-172-01
|
| Deferoxamine mesylate INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Gland Pharma Limited |
Product NDC
68083-173Package NDC
68083-173-01
|
| Deferoxamine Mesylate POWDER | TAPI Hungary Industries Kft. |
Product NDC
84671-1016Package NDC
84671-1016-0
|
| Desferal INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Novartis Pharmaceuticals Corporation |
Product NDC
0078-0467Package NDC
0078-0467-91
|
| Desferal INJECTION, POWDER, FOR SOLUTION | MITEM PHARMA |
Product NDC
87081-467Package NDC
87081-467-91
|
Need this list in your own system?
Every record on this page is available through the API, with its source, licence and retrieval date.